Fosfomycin trometamol and the single-dose treatment of cystitis Free

Preview this article:

There is no abstract available.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/00222615-41-5-293
1994-11-01
2024-03-28
Loading full text...

Full text loading...

/deliver/fulltext/jmm/41/5/medmicro-41-5-293.html?itemId=/content/journal/jmm/10.1099/00222615-41-5-293&mimeType=html&fmt=ahah

References

  1. Hendlin D, Stapley EO, Jackson M. et al. Phosphonomycin, a new antibiotic produced by strains of streptomyces. Science 1969; 166:122–123
    [Google Scholar]
  2. Christensen BG, Leanza WJ, Beattie TR. et al. Phosphonomycin: structure and synthesis. Science 1969; 166:123–125
    [Google Scholar]
  3. Kahan FM, Kahan JS, Cassidy PJ, Kropp H. The mechanisms of action of fosfomycin (phosphonomycin). Ann NY Acad Sci 1974; 235:364–386
    [Google Scholar]
  4. Zimmerman SB, Stapley EO, Wallick H, Baldwin R. Phosphonomycin. IV. Susceptibility testing method and survey. Hobby GL. (ed) Antimicrobial agents and chemotherapy—1969 Bethesda: American Society for Microbiology; 1970303–309
    [Google Scholar]
  5. Haag R., Vömel W. Einflüsse auf die Aktivität von fosfomycin in vitro. Immunität und Infektion 1979; 7:202–209
    [Google Scholar]
  6. Greenwood D, Jones A, Eley A. Factors influencing the activity of the trometamol salt of fosfomycin. Eur J Clin Microbiol 1986; 5:29–34
    [Google Scholar]
  7. Llaneza J, Villar CJ, Salas JA, Suarez JE, Mendoza MC, Hardisson C. Plasmid-mediated fosfomycin resistance is due to enzymic modification of the antibiotic. Antimicrob Agents Chemother 1985; 28:163–164
    [Google Scholar]
  8. Arca P, Rico M, Brana AF, Villar CJ, Hardisson C, Suárez JE. Formation of an adduct between fosfomycin and glutathione: a new mechanism of antibiotic resistance in bacteria. Antimicrob Agents Chemother 1988; 21:1552–1556
    [Google Scholar]
  9. Suárez JE, Mendoza MC. Plasmid-encoded fosfomycin resistance. Antimicrob Agents Chemother 1991; 35:791–795
    [Google Scholar]
  10. Ferrari V, Bonanomi L, Borgia M, Lodola E, Marca G. A new fosfomycin derivative with much improved bioavailability by oral route. Chemioterapia Antimicrobica 1981; 4:59–63
    [Google Scholar]
  11. Wilson P, Williams JD, Rolandi E. Comparative pharmacokinetics of fosfomycin trometamol, sodium fosfomycin and calcium fosfomycin in humans. Neu HC, Williams JD. (eds) New trends in urinary tract infections Basel: Karger; 1988136–142
    [Google Scholar]
  12. Segre G, Bianchi E, Cataldi A, Zannini G. Pharmacokinetic profile of fosfomycin trometamol (Monuril). Eur Urol 1987; 13:Suppl 156–63
    [Google Scholar]
  13. Charlton CAC, Crowther A, Davies JG. et al. Three-day and ten-day chemotherapy for urinary tract infections in general practice. BMJ 1976; 1:124–126
    [Google Scholar]
  14. Bailey RR, Abbott GD. Treatment of urinary-tract infections with a single dose of amoxycillin. NZ Med J 1976; 8:324
    [Google Scholar]
  15. Bailey RR, Abbott GD. Treatment of urinary-tract infection with a single dose of amoxycillin. Nephron 1977; 18:316–320
    [Google Scholar]
  16. Bailey RR, Abbott GD. Treatment of urinary tract infection with a single dose of trimethoprim-sulphamethoxazole. Can Med Assoc J 1978; 118:551–552
    [Google Scholar]
  17. Grüneberg RN Brumfitt W. Single-dose treatment of acute urinary tract infection: a controlled trial. BMJ 1967; 3:649–651
    [Google Scholar]
  18. Greenwood D, Kawada Y, O’Grady F. Treatment of acute bacterial cystitis: economy versus efficacy. Lancet 1980; 1:197
    [Google Scholar]
  19. Brumfitt W, Hamilton-Miller JMT. The optimal duration of antibiotic treatment of urinary infections. Neu HC, Williams JD. (eds) New trends in urinary tract infections Basel: Karger; 198862–77
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/00222615-41-5-293
Loading

Most cited Most Cited RSS feed